Quantitative optical spectroscopy: a robust tool for direct measurement of breast cancer vascular oxygenation and total hemoglobin content in vivo.

We propose the use of a robust, biopsy needle-based, fiber-optic tool for routine clinical quantification of tumor oxygenation at the time of diagnostic biopsy for breast cancer. The purpose of this study was to show diffuse reflectance spectroscopy as a quantitative tool to measure oxygenation levels in the vascular compartment of breast cancers in vivo via an optical biopsy technique. Thirty-five patients undergoing surgical treatment for breast cancer were recruited for the study at Duke University Medical Center. Diffuse reflectance spectroscopy was performed on the tumors in situ before surgical resection, followed by needle-core biopsy of the optically measured tissue. Hemoglobin saturation and total hemoglobin content were quantified from 76 optical spectra-tissue biopsy pairs, consisting of 20 malignant, 23 benign, and 33 adipose tissues. Hemoglobin saturation in malignant tissues was significantly lower than nonmalignant tissues (P<0.002) and was negatively correlated with tumor size and pathologic tumor category (P<0.05). Hemoglobin saturation was positively correlated with total hemoglobin content in malignant tissues (P<0.02). HER2/neu-amplified tumors exhibited significantly higher total hemoglobin content (P<0.05) and significantly higher hemoglobin saturation (P<0.02), which is consistent with a model of increased angiogenesis and tumor perfusion promoted by HER2/neu amplification. Diffuse reflectance spectroscopy could aid in prognosis and prediction in breast cancer via quantitative assessment of tumor physiology at the time of diagnostic biopsy.

[1]  P. Vaupel,et al.  O2 supply conditions in tumor tissue in vivo. , 1976, Advances in experimental medicine and biology.

[2]  M. Dewhirst,et al.  Review of methods used to study oxygen transport at the microcirculatory level , 2000, International journal of cancer.

[3]  J. Brown,et al.  Exploiting tumour hypoxia in cancer treatment , 2004, Nature Reviews Cancer.

[4]  Nirmala Ramanujam,et al.  Monte-Carlo-based model for the extraction of intrinsic fluorescence from turbid media. , 2008, Journal of biomedical optics.

[5]  Alexandru Daşu,et al.  The relationship between vascular oxygen distribution and tissue oxygenation. , 2009, Advances in experimental medicine and biology.

[6]  P. Vaupel,et al.  Tumor hypoxia and malignant progression. , 2009, Methods in enzymology.

[7]  I. Hedenfalk,et al.  ERK1/2 inhibition increases antiestrogen treatment efficacy by interfering with hypoxia-induced downregulation of ERα: a combination therapy potentially targeting hypoxic and dormant tumor cells , 2005, Oncogene.

[8]  M. Zavelevich,et al.  Tumor hypoxia and malignant progression. , 2009, Experimental oncology.

[9]  Michael Höckel,et al.  Detection and characterization of tumor hypoxia using pO2 histography. , 2007, Antioxidants & redox signaling.

[10]  J. Giammarco,et al.  Bulk optical properties of healthy female breast tissue , 2002, Physics in medicine and biology.

[11]  Emmanuel Chamorey,et al.  HIF‐1α and CA IX staining in invasive breast carcinomas: Prognosis and treatment outcome , 2007 .

[12]  J. Gaa,et al.  Oxygenation of mammary tumors as evaluated by ultrasound-guided computerized-pO2-histography. , 1994, Advances in experimental medicine and biology.

[13]  Brian W. Pogue,et al.  Interpreting hemoglobin and water concentration, oxygen saturation, and scattering measured in vivo by near-infrared breast tomography , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[14]  L. J. Schelven Thermochemoradiotherapy improves oxygenation in locally advanced breast cancer , 2004 .

[15]  K. T. Moesta,et al.  Concentration and oxygen saturation of haemoglobin of 50 breast tumours determined by time-domain optical mammography. , 2004, Physics in medicine and biology.

[16]  E. Conant,et al.  Breast Cancer Detection Based on Incremental Biochemical and Physiological Properties of Breast Cancers , 2005 .

[17]  M. Alber,et al.  Imaging oxygenation of human tumours , 2006, European Radiology.

[18]  P. Vaupel,et al.  Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response. , 2004, The oncologist.

[19]  P Vaupel,et al.  Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. , 1996, Cancer research.

[20]  L. Murphy,et al.  Intermittent Hypoxia Induces Proteasome-Dependent Down-Regulation of Estrogen Receptor α in Human Breast Carcinoma , 2004, Clinical Cancer Research.

[21]  Michael Höckel,et al.  Oxygenation gain factor: a novel parameter characterizing the association between hemoglobin level and the oxygenation status of breast cancers. , 2003, Cancer research.

[22]  Judith R. Mourant,et al.  Light scattering from cells: the contribution of the nucleus and the effects of proliferative status , 2000 .

[23]  M. Dewhirst,et al.  Longitudinal Monitoring of 4T1-Tumor Physiology in vivo with Doxorubicin Treatment via Diffuse Optical Spectroscopy , 2008 .

[24]  Alexandru Daşu,et al.  Vascular oxygen content and the tissue oxygenation--a theoretical analysis. , 2008, Medical physics.

[25]  N. Ramanujam,et al.  Monte Carlo-based inverse model for calculating tissue optical properties. Part I: Theory and validation on synthetic phantoms. , 2006, Applied optics.

[26]  Arjen Amelink,et al.  Optical biopsy of breast tissue using differential path-length spectroscopy , 2005, Physics in medicine and biology.

[27]  P. Vaupel,et al.  Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. , 2001, Journal of the National Cancer Institute.

[28]  SJ Falk,et al.  The influence of carbogen breathing on tumour tissue oxygenation in man evaluated by computerised p02 histography. , 1992, British journal of cancer.

[29]  O. S. Nielsen,et al.  The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas. , 1996, International journal of radiation oncology, biology, physics.

[30]  P. Vaupel,et al.  Blood supply, oxygenation status and metabolic micromilieu of breast cancers: characterization and therapeutic relevance. , 2000, International journal of oncology.

[31]  P. Vaupel,et al.  Relationship between size and oxygenation status of malignant tumors. , 1983, Advances in experimental medicine and biology.

[32]  Peter M. Schlag,et al.  Tumor oxygenation correlates with molecular growth determinants in breast cancer , 1998, Breast Cancer Research and Treatment.

[33]  J Martin Brown,et al.  Tumor hypoxia in cancer therapy. , 2007, Methods in enzymology.

[34]  E. Rosen,et al.  Ultrasound guided pO 2 measurement of breast cancer reoxygenation after neoadjuvant chemotherapy and hyperthermia treatment , 2003, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[35]  G. Semenza,et al.  HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression , 2001, Molecular and Cellular Biology.

[36]  Peter Vaupel,et al.  The role of hypoxia-induced factors in tumor progression. , 2004, The oncologist.

[37]  M. Dewhirst,et al.  HER-2 Gene Amplification Correlates with Higher Levels of Angiogenesis and Lower Levels of Hypoxia in Primary Breast Tumors , 2004, Clinical Cancer Research.

[38]  Emmanuel Chamorey,et al.  HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome. , 2007, International journal of cancer.

[39]  P. Vaupel,et al.  Heterogeneous oxygenation of rectal carcinomas in humans: a critical parameter for preoperative irradiation? , 1984, Advances in experimental medicine and biology.

[40]  Nirmala Ramanujam,et al.  Diagnosis of breast cancer using diffuse reflectance spectroscopy: Comparison of a Monte Carlo versus partial least squares analysis based feature extraction technique , 2006, Lasers in surgery and medicine.

[41]  N. Ramanujam,et al.  Comparison of a physical model and principal component analysis for the diagnosis of epithelial neoplasias in vivo using diffuse reflectance spectroscopy. , 2007, Optics express.

[42]  L. Svaasand,et al.  Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy. , 2000, Neoplasia.

[43]  P Vaupel,et al.  Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy. , 2001, Seminars in oncology.

[44]  Karthik Vishwanath,et al.  A Robust Monte Carlo Model for the Extraction of Biological Absorption and Scattering In Vivo , 2009, IEEE Transactions on Biomedical Engineering.

[45]  A. Al Moustafa,et al.  The role of ErbB-2 tyrosine kinase receptor in cellular intrinsic chemoresistance: mechanisms and implications. , 1997, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[46]  M. Dewhirst,et al.  Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. , 1996, Cancer research.

[47]  C. Koch,et al.  Prognostic significance of tumor oxygenation in humans. , 2003, Cancer letters.

[48]  B. Tromberg,et al.  Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy , 2007, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Nirmala Ramanujam,et al.  Monte Carlo-based inverse model for calculating tissue optical properties. Part II: Application to breast cancer diagnosis. , 2006, Applied optics.

[50]  P Vaupel,et al.  Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. , 1991, Cancer research.

[51]  E. Conant,et al.  Breast cancer detection based on incremental biochemical and physiological properties of breast cancers: a six-year, two-site study. , 2005, Academic radiology.

[52]  P Vaupel,et al.  Intracapillary oxyhemoglobin saturation of malignant tumors in humans. , 1981, International journal of radiation oncology, biology, physics.

[53]  M. Hung,et al.  HER-2/Neu signaling and therapeutic approaches in breast cancer. , 2002, Breast disease.